Answers are grounded in this paper and cite their sources.
Antiviral therapy is underutilized for outpatients at increased risk for severe COVID-19 or influenza. Results from this survey offer insights into treatment barriers from the infectious disease specialist perspective. Further education is needed about the benefits of early antiviral therapy.
No takes yet. Share an insight, caveat, or question.
SINGLETON et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: